Announced
Completed
Synopsis
The Carlyle Group completed the acquisition of a 20% stake in Piramal Pharma, the pharmaceutical business of Piramal, a diversified global business conglomerate, for c.$481m. “We are pleased to announce the strategic growth investment by Carlyle, a marquee global investor, in Piramal Pharma. This infusion of funds will further strengthen our balance sheet and provide us with a war chest for the next phase of our strategy. We are pleased to have an investor of this calibre join the Piramal family and continue our stellar track record of partnerships,” Ajay Piramal, Piramal Enterprises Chairman.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.